Published in Am J Psychiatry on January 01, 2003
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Neurobiology of resilience. Nat Neurosci (2012) 2.13
Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res (2012) 1.72
Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend (2007) 1.40
Illicit anabolic-androgenic steroid use. Horm Behav (2009) 1.35
Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol (2011) 1.03
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast (2013) 0.94
Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol (2013) 0.94
Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav (2009) 0.93
Treatment of Men for "Low Testosterone": A Systematic Review. PLoS One (2016) 0.90
Interindividual Variability in Stress Susceptibility: A Role for Epigenetic Mechanisms in PTSD. Front Psychiatry (2013) 0.89
Interactions of sexual activity, gender, and depression with immunity. J Sex Med (2013) 0.88
Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci (2008) 0.88
On the effects of testosterone on brain behavioral functions. Front Neurosci (2015) 0.86
Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience (2010) 0.85
Cognitive effects of testosterone and finasteride administration in older hypogonadal men. Clin Interv Aging (2014) 0.85
A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Can Urol Assoc J (2010) 0.85
The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in Gonadectomized Male Rats. Biol Psychiatry (2015) 0.84
Peripheral and Central Mechanisms of Stress Resilience. Neurobiol Stress (2015) 0.84
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opin Pharmacother (2010) 0.84
Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones. Horm Behav (2015) 0.84
Relationship between testosterone levels and depressive symptoms in older men in Amirkola, Iran. Caspian J Intern Med (2014) 0.82
The many faces of testosterone. Clin Interv Aging (2007) 0.82
Partial androgen deficiency, depression, and testosterone supplementation in aging men. Int J Endocrinol (2012) 0.80
Testosterone replacement therapy for older men. Clin Interv Aging (2007) 0.80
Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis. Clin Exp Nephrol (2012) 0.80
Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr (2009) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder. Mol Psychiatry (2015) 0.79
Neurobiological mechanisms supporting experience-dependent resistance to social stress. Neuroscience (2015) 0.79
An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression. Psychiatry (Edgmont) (2006) 0.78
Hormone treatment of depression. Dialogues Clin Neurosci (2011) 0.77
Nonprescription steroids on the Internet. Subst Use Misuse (2011) 0.77
Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study. Psychoneuroendocrinology (2007) 0.77
[New insights into the pathogenesis and pathophysiology of depression]. Nervenarzt (2007) 0.76
Testosterone and Cardiovascular Disease. Open Cardiovasc Med J (2016) 0.76
Tackling partial response to depression treatment. Prim Care Companion J Clin Psychiatry (2009) 0.75
Brain SERT Expression of Male Rats Is Reduced by Aging and Increased by Testosterone Restitution. Neurosci J (2013) 0.75
The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort. AIDS Res Ther (2015) 0.75
Testosterone replacement in male hypogonadism. Clin Pharmacol (2010) 0.75
The Effects of Gender Differences in Patients with Depression on Their Emotional Working Memory and Emotional Experience. Behav Neurol (2015) 0.75
Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome. World J Mens Health (2017) 0.75
A potential relationship between diffuse musculoskeletal pain and hypogonadism. BMJ Case Rep (2010) 0.75
Testosterone deficiency in adults and corresponding treatment patterns across the globe. Transl Androl Urol (2017) 0.75
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction (2011) 3.42
Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature. Psychol Med (2006) 2.70
Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend (2003) 2.68
Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation (2006) 2.40
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med (2002) 2.34
Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail (2010) 2.32
The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry (2013) 2.31
Family study of fibromyalgia. Arthritis Rheum (2004) 2.22
Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003. Psychother Psychosom (2006) 2.14
Anabolic-androgenic steroid dependence: an emerging disorder. Addiction (2009) 2.03
Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry (2007) 2.01
Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry (2009) 1.72
The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry (2007) 1.71
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend (2008) 1.65
Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend (2004) 1.61
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum (2007) 1.61
Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry (2006) 1.61
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry (2003) 1.55
Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med (2008) 1.54
Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry (2008) 1.50
Binge eating disorder: a stable syndrome. Am J Psychiatry (2006) 1.49
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry (2007) 1.42
Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther (2011) 1.41
Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol (2002) 1.38
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
Illicit anabolic-androgenic steroid use. Horm Behav (2009) 1.35
Anabolic steroid users' attitudes towards physicians. Addiction (2004) 1.30
Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology (2005) 1.28
Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend (2003) 1.25
Cognitive measures in long-term cannabis users. J Clin Pharmacol (2002) 1.23
Family studies of borderline personality disorder: a review. Harv Rev Psychiatry (2003) 1.23
Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry (2006) 1.20
Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend (2006) 1.18
Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord (2008) 1.17
Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry (2003) 1.11
Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend (2010) 1.09
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry (2006) 1.07
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend (2009) 1.04
Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry (2010) 1.03
Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry (2011) 1.01
Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry (2007) 1.01
Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord (2004) 1.00
Pharmacologic treatment of binge eating disorder. Int J Eat Disord (2003) 1.00
Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry (2004) 0.99
Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders. J Pers Disord (2009) 0.99
Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab (2008) 0.99
Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology (2007) 0.98
Role of antiepileptic drugs in the management of eating disorders. CNS Drugs (2009) 0.98
Social scientific paradigms of masculinity and their implications for research and practice in men's mental health. J Clin Psychol (2005) 0.97
A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry (2002) 0.96
Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry (2011) 0.95
Human growth hormone abuse in male weightlifters. Am J Addict (2010) 0.95
Is PTSD caused by traumatic stress? J Anxiety Disord (2006) 0.95
Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum (2012) 0.93
Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. Am J Clin Pathol (2006) 0.93
The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict (2013) 0.93
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord (2011) 0.92
Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol (2010) 0.92
Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry (2003) 0.92
Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. Int J Eat Disord (2011) 0.92
A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol (2010) 0.90
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol (2008) 0.90
Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activation. Am J Clin Pathol (2006) 0.90
Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clin J Sport Med (2015) 0.90
Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend (2004) 0.89
Memantine in the treatment of binge eating disorder: an open-label, prospective trial. Int J Eat Disord (2008) 0.89
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. Int Clin Psychopharmacol (2009) 0.88
Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol (2009) 0.87
Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol (2008) 0.87
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. J Clin Psychiatry (2004) 0.87
Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Ther (2003) 0.86
Estimating disease prevalence using relatives of case and control probands. Biometrics (2009) 0.85
Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology (2001) 0.85
Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict (2013) 0.85
Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend (2012) 0.85
Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab (2003) 0.85
Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. Neuropsychopharmacology (2005) 0.82
Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction (2015) 0.82
Outcomes of surgical management of total HIP replacement in patients aged 65 years and older: cemented versus cementless femoral components and lateral or anterolateral versus posterior anatomical approach. J Orthop Res (2002) 0.81
Placebo response in binge eating disorder. Int J Eat Disord (2007) 0.81
Binge eating disorder: the next generation of research. Int J Eat Disord (2013) 0.80
Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom (2012) 0.80
Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry (2005) 0.80
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. Int J Eat Disord (2011) 0.79
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain (2009) 0.79
A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol (2013) 0.78
Stroke and myocardial infarction with hormonal contraception. N Engl J Med (2012) 0.78
Childhood body-focused behaviors and social behaviors as risk factors of eating disorders. Psychother Psychosom (2005) 0.77
Practical management of exercise-associated hyponatremic encephalopathy: the sodium paradox of non-osmotic vasopressin secretion. Clin J Sport Med (2008) 0.77
National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train (2012) 0.77